NCT03257202View on ClinicalTrials.gov

Topical Treatment and Prevalence of P. Acnes

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

January 1, 2018

Study Completion Date

January 1, 2018

Conditions
Surgical Site Infection
Interventions
DRUG

Clindamycin 1% Gel

topical clindamycin

DRUG

Benzoyl peroxide 5% gel

topical benzoyl peroxide

DRUG

BenzaClin 5%-1% Topical Gel

Topical clindamycin and benzoyl peroxide together

Trial Locations (1)

90033

Keck School of Medicine of the University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT03257202 - Topical Treatment and Prevalence of P. Acnes | Biotech Hunter | Biotech Hunter